Matches in Nanopublications for { ?s ?p "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP936310.RAU9dx2b2yyZ9yyMLcW0hiwG7K_fn2NADqg-eRLi-jO4c130_assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936310.RAU9dx2b2yyZ9yyMLcW0hiwG7K_fn2NADqg-eRLi-jO4c130_provenance.
- NP597084.RA_LjhLGLCfgx9Hoh2F0aRRXmkMphASaCULMCr8o17H8s130_assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597084.RA_LjhLGLCfgx9Hoh2F0aRRXmkMphASaCULMCr8o17H8s130_provenance.
- NP443307.RArp3QnJWRxXKIDiF2WJRZwSD4G4dY0FlOB2FLW-1QfjQ130_assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP443307.RArp3QnJWRxXKIDiF2WJRZwSD4G4dY0FlOB2FLW-1QfjQ130_provenance.
- NP825727.RAl_Hn9YCOLvLTVJMgefz9kXpOlDOOReX9J0sU9dXcgds130_assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825727.RAl_Hn9YCOLvLTVJMgefz9kXpOlDOOReX9J0sU9dXcgds130_provenance.
- NP342020.RAMz12WvVlMaPfLyAmkpuQyROqhVDUGAzIVE9CV-aBJ_I130_assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342020.RAMz12WvVlMaPfLyAmkpuQyROqhVDUGAzIVE9CV-aBJ_I130_provenance.
- NP893873.RA7CfPDtGxFlGtUhFUu6x2G3Nesx9C-EeRS-56ElDsVkA130_assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893873.RA7CfPDtGxFlGtUhFUu6x2G3Nesx9C-EeRS-56ElDsVkA130_provenance.
- assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP263034.RAaTNXO62MPkcx3x_Lg9BotdCO1i9ReckadRjrDwyFkHg130_assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263034.RAaTNXO62MPkcx3x_Lg9BotdCO1i9ReckadRjrDwyFkHg130_provenance.
- NP263036.RAn0V_OQXFpGfVbGf1eo80mehtrdbc7DrBPROUAmjP5Ck130_assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263036.RAn0V_OQXFpGfVbGf1eo80mehtrdbc7DrBPROUAmjP5Ck130_provenance.
- NP263032.RAEpMnyUFETzQIpDQz0nswhlPUi6WMPWdde1xIgSloVS0130_assertion description "[These results indicate that somatostatin analog RC-160 inhibits the growth of HEC-1 human endometrial cancer cells, thus implying its potential clinical utility in treating endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263032.RAEpMnyUFETzQIpDQz0nswhlPUi6WMPWdde1xIgSloVS0130_provenance.